| Emilee A Witt, MA | |
|
W6127 Lorna Ln, Appleton, WI 54915-7465 | |
| (920) 840-3033 | |
| (920) 882-4009 |
| Full Name | Emilee A Witt |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | W6127 Lorna Ln, Appleton, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689304016 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emilee A Witt, MA W6127 Lorna Ln, Appleton, WI 54915-7465 Ph: (920) 840-3033 | Emilee A Witt, MA W6127 Lorna Ln, Appleton, WI 54915-7465 Ph: (920) 840-3033 |
News Archive
Sen. Tom Harkin (D-IA), chair of the Senate Health, Education, Labor and Pensions Committee and long-time advocate of prevention, will keynote a National Journal Policy Summit focused on unraveling the complexities of the cost and value of prevention in a post health reform world. The Sept. 21 event is being underwritten by the American Clinical Laboratory Association and its educational arm, Results for Life.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg for the treatment of chronic hepatitis C genotype 1 infection in adults.
In a significant breakthrough, investigators at Weill Cornell Medical College and the University of California, San Francisco, have been able to overcome resistance of a form of leukemia to targeted therapy, demonstrating complete eradication of the cancer in cell and animal studies.
Scientists from the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, and the National Heart, Lung and Blood Institute all parts of the National Institutes of Health, describe how combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumors.
› Verified 9 days ago
Patricia Lyons, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3305 N Ballard Rd Ste C, Appleton, WI 54911 Phone: 920-735-9234 | |
Tanya L Armstrong, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: N9463 Bloomingrose Ln, Appleton, WI 54915 Phone: 920-993-1912 | |
Ellen Christiaansen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1506 S Oneida St, Appleton, WI 54915 Phone: 920-738-2960 | |
Kathleen Ann Reschar, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325 E Florida Ave, Appleton, WI 54911 Phone: 920-731-7310 | |
Miss Heidi Ann Teal, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3375 W Brewster St, Appleton, WI 54914 Phone: 920-749-5870 | |
Kendra Clayton, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2451 N Lynndale Dr, Appleton, WI 54914 Phone: 920-655-0687 | |
Therapy Time For Kids Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: W2544 Buchanan Rd, Appleton, WI 54915 Phone: 920-840-3033 Fax: 888-883-1209 |